chr11-36462565-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001160167.2(PRR5L):c.936G>T(p.Leu312Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00239 in 1,612,760 control chromosomes in the GnomAD database, including 82 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 47 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 35 hom. )
Consequence
PRR5L
NM_001160167.2 synonymous
NM_001160167.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0410
Genes affected
PRR5L (HGNC:25878): (proline rich 5 like) Enables ubiquitin protein ligase binding activity. Involved in several processes, including TORC2 signaling; positive regulation of mRNA catabolic process; and regulation of fibroblast migration. Part of TORC2 complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 11-36462565-G-T is Benign according to our data. Variant chr11-36462565-G-T is described in ClinVar as [Benign]. Clinvar id is 790088.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.041 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0134 (2042/152288) while in subpopulation AFR AF= 0.0463 (1926/41564). AF 95% confidence interval is 0.0446. There are 47 homozygotes in gnomad4. There are 954 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 47 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRR5L | NM_001160167.2 | c.936G>T | p.Leu312Leu | synonymous_variant | 9/9 | ENST00000530639.6 | NP_001153639.1 | |
PRR5L | NM_024841.5 | c.936G>T | p.Leu312Leu | synonymous_variant | 10/10 | NP_079117.3 | ||
PRR5L | NM_001160168.2 | c.552G>T | p.Leu184Leu | synonymous_variant | 6/6 | NP_001153640.1 | ||
PRR5L | NM_001160169.1 | c.*191G>T | 3_prime_UTR_variant | 7/7 | NP_001153641.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRR5L | ENST00000530639.6 | c.936G>T | p.Leu312Leu | synonymous_variant | 9/9 | 2 | NM_001160167.2 | ENSP00000435050.1 |
Frequencies
GnomAD3 genomes AF: 0.0133 AC: 2031AN: 152170Hom.: 47 Cov.: 32
GnomAD3 genomes
AF:
AC:
2031
AN:
152170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00340 AC: 840AN: 247064Hom.: 14 AF XY: 0.00228 AC XY: 306AN XY: 133982
GnomAD3 exomes
AF:
AC:
840
AN:
247064
Hom.:
AF XY:
AC XY:
306
AN XY:
133982
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00125 AC: 1819AN: 1460472Hom.: 35 Cov.: 30 AF XY: 0.00107 AC XY: 774AN XY: 726508
GnomAD4 exome
AF:
AC:
1819
AN:
1460472
Hom.:
Cov.:
30
AF XY:
AC XY:
774
AN XY:
726508
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0134 AC: 2042AN: 152288Hom.: 47 Cov.: 32 AF XY: 0.0128 AC XY: 954AN XY: 74456
GnomAD4 genome
AF:
AC:
2042
AN:
152288
Hom.:
Cov.:
32
AF XY:
AC XY:
954
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at